Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EBIT (2020 - 2025)

Historic EBIT for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $114.3 million.

  • Sotera Health's EBIT rose 4193.42% to $114.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $371.5 million, marking a year-over-year increase of 1812.63%. This contributed to the annual value of $297.6 million for FY2024, which is 756.58% up from last year.
  • Per Sotera Health's latest filing, its EBIT stood at $114.3 million for Q3 2025, which was up 4193.42% from $97.7 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's EBIT registered a high of $114.3 million during Q3 2025, and its lowest value of $33.4 million during Q1 2023.
  • Over the past 5 years, Sotera Health's median EBIT value was $71.5 million (recorded in 2022), while the average stood at $71.8 million.
  • Within the past 5 years, the most significant YoY rise in Sotera Health's EBIT was 7288.92% (2023), while the steepest drop was 3762.43% (2023).
  • Quarter analysis of 5 years shows Sotera Health's EBIT stood at $66.4 million in 2021, then dropped by 9.42% to $60.2 million in 2022, then surged by 72.89% to $104.0 million in 2023, then fell by 16.23% to $87.1 million in 2024, then skyrocketed by 31.12% to $114.3 million in 2025.
  • Its EBIT was $114.3 million in Q3 2025, compared to $97.7 million in Q2 2025 and $72.4 million in Q1 2025.